GLS and small cell carcinoma: However, as the disease progresses into CRPC and small cell neuroendocrine carcinoma, the expressed GLS1 isoform shifts to a more enzymatically active and AR-independent GAC variant, enabling advanced PCa cells to preferentially utilise glutamine over glucose to fuel the TCA cycle [13,24].